GlaxoSmithKline (5 OTC drugs)
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Portfolio of 5 Over The Counter drugs of GlaxoSmithKline headquartered in England, United Kingdom. The portfolio of drugs consists of five brands well recommended by physicians.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- Brentford TW8
- England, United Kingdom
GlaxoSmithKline (5 OTC drugs) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore GlaxoSmithKline (5 OTC drugs)‘s full profile, request access.
Request full access to PitchBookGlaxoSmithKline (5 OTC drugs) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore GlaxoSmithKline (5 OTC drugs)‘s full profile, request access.
Request full access to PitchBook